Vor Biopharma (VOR) Preferred Dividend Payments (2020 - 2021)
Vor Biopharma's (VOR) quarterly Preferred Dividend Payments came in at $1.2 million in Q1 2021, up 71.75% year-on-year from $715000.0 in Q1 2020, and down 43.41% on a QoQ basis from $2.2 million in Q4 2020.
Vor Biopharma (VOR) Preferred Dividend Payments (2020 - 2021) Analysis & Trends
Vor Biopharma (VOR) has 2 years of Preferred Dividend Payments data on file, last reported at $1.2 million in Q1 2021.
- On a quarterly basis, Preferred Dividend Payments rose 71.75% year-over-year to $1.2 million in Q1 2021; TTM through Dec 2021 was $1.2 million, a 79.27% decrease from a year earlier, with the FY2021 full-year figure at $1.2 million, down 79.27% from the prior year.
- Preferred Dividend Payments for Q1 2021 stood at $1.2 million, down from $2.2 million in the prior quarter.
- Over the last five years, Preferred Dividend Payments for VOR reached as high as $2.2 million in Q3 2020 and fell as low as $715000.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Vor Biopharma | 187.37 Mn | 187.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 1.23 Mn |
| Dec 31, 2020 | 2.17 Mn |
| Sep 30, 2020 | 2.19 Mn |
| Jun 30, 2020 | 855,000.00 |
| Mar 31, 2020 | 715,000.00 |